Ignite Creation Date:
2025-12-25 @ 1:26 AM
Ignite Modification Date:
2026-01-04 @ 10:13 AM
Study NCT ID:
NCT00254293
Status:
COMPLETED
Last Update Posted:
2014-04-08
First Post:
2005-11-15
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study to Assess Steady-State Trough Concentrations, Safety, and Immunogenicity of Abatacept After Subcutaneous (SC) Administration to Subjects With Rheumatoid Arthritis (RA)
Sponsor:
Bristol-Myers Squibb
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-01
Start Date Type:
None
Primary Completion Date:
2007-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-07
Completion Date Type:
ACTUAL
First Submit Date:
2005-11-15
First Submit QC Date:
None
Study First Post Date:
2005-11-16
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2013-08-20
Results First Submit QC Date:
None
Results First Post Date:
2014-04-08
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-03-03
Last Update Post Date:
2014-04-08
Last Update Post Date Type:
ESTIMATED